IGC Pharma (IGC) Revenue Growth (1y) (2011 - 2025)
IGC Pharma (IGC) Revenue Growth (1y) (2011 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Revenue Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
788,338.31 Bn |
788,338.28 Bn |
- |
37.90% |
| 2 |
Belite Bio |
56,560.00 Bn |
56,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,329.30 Bn |
17,329.30 Bn |
- |
- |
| 4 |
Legend Biotech |
3,341.00 Bn |
3,340.71 Bn |
242.10 Mn |
64.24% |
| 5 |
Akari Therapeutics |
1,727.91 Bn |
1,727.91 Bn |
- |
- |
| 6 |
Evaxion A |
1,536.68 Bn |
1,536.67 Bn |
- |
- |
| 7 |
Psyence Biomedical |
238.34 Bn |
238.33 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.42 Bn |
106.17 Bn |
2.59 Bn |
7.82% |
| 9 |
Abivax |
95.45 Bn |
95.45 Bn |
- |
- |
| 10 |
IGC Pharma |
28.11 Mn |
27.85 Mn |
- |
- |
| Date | Value |
|---|
| Sep 30, 2025 |
-53.64% |
| Jun 30, 2025 |
20.59% |
| Mar 31, 2025 |
11.86% |
| Dec 31, 2024 |
25.98% |
| Sep 30, 2024 |
41.58% |
| Jun 30, 2024 |
-50.99% |
| Mar 31, 2024 |
77.71% |
| Dec 31, 2023 |
-38.55% |
| Sep 30, 2023 |
44.06% |
| Jun 30, 2023 |
161.79% |
| Mar 31, 2023 |
36.07% |
| Dec 31, 2022 |
133.80% |
| Sep 30, 2022 |
260.71% |
| Jun 30, 2022 |
175.32% |
| Mar 31, 2022 |
50.62% |
| Dec 31, 2021 |
31.48% |
| Sep 30, 2021 |
-55.20% |
| Jun 30, 2021 |
-86.82% |
| Mar 31, 2021 |
179.31% |
| Dec 31, 2020 |
-81.15% |
